ACH receptors can be defined as an integral membrane protein that responds to the binding of acetylcholine, a neuoyansmitter. Two example are nicotinic acetyl line receptors and muscarinic acetylcholine receptors. .
Nicotinic ACh receptors are ionotropic receptors that mediate fast neurotransmission, while muscarinic ACh receptors are metabotropic receptors that modulate cell signaling through G-proteins. Nicotinic receptors are typically found at neuromuscular junctions and in the central nervous system, whereas muscarinic receptors are more widely distributed in peripheral tissues and the brain.
Acetylcholine or aka ACH is the neurotransmitter that is released from the axon terminal to through the neuromuscular junction across the synaptic cleft which binds to the ACH receptors on the end motor plate of the Sarcolema.
Acetylcholine receptors are located on the motor end plate of the muscle cell membrane. This specialized region is where the nerve cell communicates with the muscle cell, allowing for the initiation of muscle contraction in response to acetylcholine binding to its receptors.
There are more cold receptors in the skin than warm receptors.
The sensory receptors for smell are referred to as olfactory receptors.
Nicotinic ACh receptors are ionotropic receptors that mediate fast neurotransmission, while muscarinic ACh receptors are metabotropic receptors that modulate cell signaling through G-proteins. Nicotinic receptors are typically found at neuromuscular junctions and in the central nervous system, whereas muscarinic receptors are more widely distributed in peripheral tissues and the brain.
ACh (acetylcholine) binds to receptors at the NMJ (neuromuscular junction) to induce contraction of muscle.
Acetylcholine (ACh) receptors are primarily found in the neuromuscular junctions of skeletal muscles, where they play a crucial role in muscle contraction by responding to the neurotransmitter acetylcholine. Additionally, ACh receptors are present in the central and peripheral nervous systems, where they mediate various functions including cognition, memory, and autonomic nervous system responses. There are two main types of ACh receptors: nicotinic receptors, which are ionotropic and found at neuromuscular junctions and autonomic ganglia, and muscarinic receptors, which are metabotropic and found in various tissues including the heart and glands.
AChE destroys the ACh and they are removed from the membrane receptors.
ACh esterase, which breaks ACh down into an acetyl group and a choline group. This is then taken up by the neurone and some is reformed into ACh.
Neostigmine is a competitive irreversible inhibitor of Acetylcholinesterase (AChE), an enzyme responsible for breaking down acetylcholine (ACh). Myasthenia gravis is caused by the body producing too little ACh receptors. As stimulating the ACh receptors is needed for nervous transmission, the nerve signals cannot be transmitted causing muscle weakness and fatigue. Neostigmine is hence used to inhibit AChE so that less ACh gets broken down. This leads to more ACh binding to the ACh receptors causing muscular contraction.
they stimulate the action of ACh at post ganglionic muscarinic receptors.
A deficiency of ACh receptors in a motor end plate would cause muscle weakness or paralysis. This condition is called myasthenia gravis.
Competes with ACh at the nerve receptors and results in under stimulatin of the receptors.
It doesn't atropine only acts on muscarinic receptors (it's a competitive antagonist here for ACh), but histamine acts on different receptors (histamine receptors). There is no direct interaction between atropine and histamine receptors
Preganglionic fibers for the SNS release ACh; so a drug that stimulates ACh receptors would stimulate the postganglionic fibers of sypathetic nerves, resulting in increased sympathetic activity
Acetylcholine is the neurotransmitter at the neuromuscular junction.